Home/Filings/4/0001209191-23-005554
4//SEC Filing

Donegan Michael C 4

Accession 0001209191-23-005554

CIK 0000025743other

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 6:40 PM ET

Size

18.9 KB

Accession

0001209191-23-005554

Insider Transaction Report

Form 4
Period: 2023-01-26
Donegan Michael C
Vice President Finance
Transactions
  • Sale

    Common Stock

    2023-01-26$5.08/sh1,648$8,37111,902 total
  • Exercise/Conversion

    Performance Stock Units

    2023-01-262,4000 total
    Exercise: $0.00Common Stock (2,400 underlying)
  • Exercise/Conversion

    Common Stock

    2023-01-26+2,40012,410 total
  • Sale

    Common Stock

    2023-01-27$5.09/sh49$24911,853 total
  • Exercise/Conversion

    Common Stock

    2023-01-26+1,14013,550 total
  • Exercise/Conversion

    Common Stock

    2023-01-26+2,40010,010 total
  • Exercise/Conversion

    Performance Stock Units

    2023-01-262,4000 total
    Exercise: $0.00Common Stock (2,400 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2023-01-261,1400 total
    Exercise: $0.00Common Stock (1,140 underlying)
Footnotes (4)
  • [F1]Each performance stock unit ("PSU") represents a contingent right to receive one share of issuer common stock upon settlement. On January 26, 2023, the reporting person received 5,940 shares of issuer common stock in settlement of performance stock units (PSUs).
  • [F2]The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.01 through $5.17, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
  • [F4]Vesting of the PSUs was accelerated in connection with the termination of the reporting person's employment agreement without "Good Cause".

Issuer

TherapeuticsMD, Inc.

CIK 0000025743

Entity typeother

Related Parties

1
  • filerCIK 0001627810

Filing Metadata

Form type
4
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 6:40 PM ET
Size
18.9 KB